EOLS CFO Awarded 104,603 RSUs; 143,403 Options at $7.61
Rhea-AI Filing Summary
Evolus, Inc. reported that its Chief Financial Officer was granted both restricted stock units and stock options on 09/08/2025. The CFO received 104,603 RSUs, each convertible into one share on settlement, and a stock option covering 143,403 shares with an exercise price of $7.61 that expires on 09/08/2035. The RSUs vest over four years with one-half vesting on each of the third and fourth anniversaries of the grant date, while the option vests in four annual tranches starting on the first anniversary. Both awards include accelerated vesting in specified termination or change‑of‑control events. Following the grants the reporting person beneficially owns 104,603 shares and has the right to acquire 143,403 additional shares under the option.
Positive
- Material equity grant of 104,603 RSUs aligns the CFO with shareholder value creation
- Large option award of 143,403 shares provides long‑term retention incentives
- Standard four‑year vesting ties compensation to continued service and performance
Negative
- Significant unvested awards represent potential dilution over the next four years
- Options exercisable at $7.61 may only have value if the share price exceeds the strike
- Accelerated vesting clauses could hasten dilution in certain terminations or change‑of‑control events
Insights
Equity grants align CFO incentives with shareholder value over a multi‑year period.
The awards combine 104,603 RSUs and a 143,403‑share option exercisable at $7.61, creating both immediate equity exposure on settlement and potential future dilution if exercised. The staggered four‑year vesting schedules tie a material portion of compensation to continued service.
Key dependencies include continued service through each vesting milestone and the company’s share price relative to the $7.61 strike for option value; accelerated vesting on certain terminations or change‑of‑control events could accelerate dilution within the next 1–4 years.
Grants follow common governance practice but increase unexercised option exposure.
The structure—time‑based RSUs plus a time‑vesting option—aligns with standard executive pay meant to retain the CFO while linking pay to equity performance. The filings show the awards are held directly by the reporting person and include customary accelerated vesting clauses.
Watch the timing of potential accelerated vesting triggers and cumulative dilution from exercised options across the next four years, which can affect outstanding share count if exercised before 09/08/2035.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 143,403 | $0.00 | -- |
| Grant/Award | Common Stock | 104,603 | $0.00 | -- |
Footnotes (1)
- Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with one-half of the RSU vesting on each of the third and fourth anniversary of September 8, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of September 8, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
